(19)

(11)

EP 2 665 702 A1

(12)

(43) Date of publication: 27.11.2013 Bulletin 2013/48 (21) Application number: 12700199.8 (22) Date of filing: 16.01.2012

(51) International Patent Classification (IPC):  C07C 269/04(2006.01) C07C 271/28(2006.01) C07C 269/06(2006.01) (86) International application number: PCT/EP2012/050559 (87) International publication number: WO 2012/098075 (26.07.2012 Gazette 2012/30)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR (30) Priority: 18.01.2011 WO PCT/EP2011/050633 20.07.2011 US 201161509802 P (71) Applicant: Glaxo Group Limited Brentford, Middlesex TW8 9GS (GB)	(72) Inventors: FITZGERALD, Russ, N North Carolina 27709 (US) MILLAR, Alan North Carolina 27709 (US) TOCZKO, Jennifer, Fell North Carolina 27709 (US) (74) Representative: Billson, Siân Catherine  GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road Brentford, Middlesex TW8 9GS Brentford, Middlesex TW8 9GS (GB)